✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹235 Cr.
P/E
18.36
  • Ambalal Sarabhai Ent
  • Balaxi Pharma.
  • Alpa Lab
FAQs on Ambalal Sarabhai Enterprises Ltd. Shareprice

Ambalal Sarabhai Ent has given better returns compared to its competitors.
Ambalal Sarabhai Ent has grown at ~0.48% over the last 3yrs while peers have grown at a median rate of -1.69%

Ambalal Sarabhai Ent is not expensive.
Latest PE of Ambalal Sarabhai Ent is 18.36, while 3 year average PE is 32.17.
Also latest EV/EBITDA of Ambalal Sarabhai Ent is 31.18 while 3yr average is 41.52.

Growth Table
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Alpa Lab
Balance Sheet
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Alpa Lab
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Alpa Lab
Cash Flow
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Alpa Lab
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Alpa Lab
Quarterly Results
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Alpa Lab
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Ambalal Sarabhai Enterprises Ltd. Financials

Balance sheet of Ambalal Sarabhai Ent is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of Ambalal Sarabhai Ent is increasing.
Latest net debt of Ambalal Sarabhai Ent is ₹25.61 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹20.67 Crs.

The profit is oscillating.
The profit of Ambalal Sarabhai Ent is ₹11.83 Crs for TTM, ₹4.93 Crs for Mar 2025 and ₹5.68 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ambalal Sarabhai Ent latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech